Using a Transection Paradigm to Enhance the Repair Mechanisms of an Investigational Human Cell Therapy
One promising strategy in cell therapies for Parkinson’s disease (PD) is to harness a patient’s own cells to provide neuroprotection in areas of the brain affected by neurodegeneration. No treatment exists to replace cells in the brain. Thus, our goal has been to support sick neurons and slow neurod...
Main Authors: | Monica J. Chau, Jorge E. Quintero, Paula V. Monje, Stephen Randal Voss, Andrew S. Welleford, Greg A. Gerhardt, Craig G. van Horne |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-09-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/09636897221123515 |
Similar Items
-
Transection injury differentially alters the proteome of the human sural nerve.
by: Monica J Chau, et al.
Published: (2022-01-01) -
Transection injury differentially alters the proteome of the human sural nerve
by: Monica J. Chau, et al.
Published: (2022-01-01) -
Gait and Balance Changes with Investigational Peripheral Nerve Cell Therapy during Deep Brain Stimulation in People with Parkinson’s Disease
by: Geetanjali Gera, et al.
Published: (2021-04-01) -
Direct delivery of an investigational cell therapy in patients with Parkinson’s disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design
by: Christopher J McLouth, et al.
Published: (2022-08-01) -
Endoscopic repair of complete bile duct transection by use of transpapillary cholangioperitoneoscopy
by: Thomas M. Runge, MD, MPH, et al.
Published: (2018-01-01)